Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Salmeterol/Fluticasone Easyhaler vs Seretide Diskus
NCT02162485Phase 1Completed
- Sponsor
- Orion Corporation
- Start
- Jun 2014
- Primary completion
- Sep 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of salmeterol + fluticasone in asthma (4 arms), sponsored by Orion Corporation. Primary endpoints: Maximum Plasma Concentration at 34 hours and Area Under the Curve to the last measurable concentration at 34 hours. Started Jun 2014; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02162485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02162485.